NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q2FY19 revenue grew by 35% YoY due to stronger performance from API (up by 30%YoY) and formulation (up by 96%YoY) exports. EBITDA rose by 104% YoY while margin is up by 1520bps primarily driven by revenue from limited competition products in the US. Received court affirmation in favor of prior decisions invalidating...